Medtronic (BUE:MDT) Tax Provision : ARS-416,540 Mil (TTM As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is Medtronic Tax Provision?

Medtronic's tax provision for the three months ended in Jan. 2024 was ARS-109,141 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jan. 2024 was ARS-416,540 Mil.

Medtronic Tax Provision Historical Data

The historical data trend for Medtronic's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Tax Provision Chart

Medtronic Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Tax Provision

Get a 7-Day Free Trial

-23,674.16

48,409.46

-24,326.47

-50,670.72

-175,569.61

Medtronic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Tax Provision	Get a 7-Day Free Trial															-25,819.93	-64,019.28	-102,680.01	-140,700.00	-109,140.75

Medtronic Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-416,540 Mil.

Medtronic (BUE:MDT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (BUE:MDT) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

MDT:USA MDTN:Mexico 1MDT:Italy 2M6:Germany 2M6:Germany 2M6:Germany 2M6:Germany MDTC34:Brazil MDT:Austria

Address

Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2

Website

https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.